Corning Highlights Impact of 3D Cell Culture on Cancer Research at AACR 2017

We use cookies to ensure the best experience on our website.
View Cookie Policy
/worldwide/en/corning-cookie-policy.html
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

This site is best viewed in a modern web browser. Please update your browser for the best experience possible.

Close[x]
news release

Corning Highlights Impact of 3D Cell Culture on Cancer Research at AACR 2017

Corning Highlights Impact of 3D Cell Culture

News Releases
CLS
Corning Highlights Impact of 3D Cell Culture on Cancer Research at AACR 2017
Corning Highlights Impact of 3D Cell Culture on Cancer Research at AACR 2017
CORNING, N.Y. | CORNING INCORPORATED | March 31, 2017
Celebrating 30 years and 10,000 citations of the Corning® Matrigel® matrix

Corning Incorporated (NYSE: GLW) will showcase its latest solutions for cancer research and drug discovery with an emphasis on 3D cell culture in exhibit 2815 at the 2017 AACR Annual Meeting, April 1-5 in Washington, D.C.

Researchers are searching for new tools and protocols as the field of 3D cell culture continues to expand and more scientists move from 2D to 3D to promote a more realistic microenvironment for their cell-based systems. From organoid and spheroid development to target discovery, Corning is helping customers create more in vivo-like studies that are accelerating cancer research and drug discovery.

Given the importance of the transition from 2D to 3D cell culture, Mark Rothenberg, manager of scientific training and education at Corning Life Sciences, will moderate an interactive panel session entitled “A Stimulating Panel Discussion Focused on 3-Dimensional Cell Culture; Systems and Questions.” The session will be at 3 p.m. Monday, April 3 in Spotlight Theater B, Hall A in the Walter E. Washington Convention Center.

Panelists will be Paul Romesser, physician scientist in the Department of Radiation Oncology at the Memorial Sloan Kettering Cancer Center; Terry Riss, global strategic manager of cell health at Promega Corporation; and Hannah Gitschier, applications laboratory manager at Corning Life Sciences. Attendees are encouraged to bring their questions regarding 3D cell culture to this highly interactive session.

In addition to the panel, Corning will celebrate 30 years and more than 10,000 citations of the Corning® Matrigel® matrix.

“Despite this product being 30 years old, Matrigel is still widely used today in many cutting-edge research applications and is often cited as the gold standard of extracellular matrices,” said Richard Eglen, Ph.D., vice president and general manager, Corning Life Sciences “Throughout the years, Matrigel users have realized remarkable scientific achievements. This encourages us to be the best in the industry, and most importantly, drive us to continue inspiring scientists to push the limits and reach new goals.”

Added Keith R. Olson, Ph.D., global director, Business Operations, Corning Life Sciences:  “As you can imagine, 10,000 citations is a significant milestone for any product. But with its capabilities ranging from stem cells, to cancer research, to drug screening applications, few products have the breadth of applications of Matrigel.”

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

To learn more about Corning Life Sciences products, contact a customer service representative at (800) 492-1110; outside the United States, call (978) 442-2200; or visit www.corning.com/lifesciences. To learn more about Corning’s 3D cell culture products, please visit:  https://www.corning.com/worldwide/en/products/life-sciences/news-events/events/2017/04/visit-corning-at-aacr-2017.html or could use www.corning.com/3D

Forward-Looking and Cautionary Statements

This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Digital Media Disclosure

In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it intends to use its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated

Corning (www.corning.com) is one of the world’s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people’s lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning’s businesses and markets are constantly evolving. Today, Corning’s products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.